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ABSTRACT
Purpose: Prenatal maternal stress affects offspring's atopic dermatitis (AD) development, 
which is thought to be mediated by the oxidative stress. We aimed to evaluate the difference 
in leukocyte telomere length (LTL), a marker for exposure to oxidative stress, according to 
the prenatal stress exposure and the later AD development.
Methods: From a birth cohort (the COhort for Childhood Origin of Asthma and allergic 
diseases) that had displayed a good epidemiologic association between the exposure to 
prenatal stress and AD development in the offspring, we selected 68 pairs of samples from 4 
subject groups based on the level of prenatal maternal stress and later AD development. The 
LTL was measured from both cord blood and 1-year peripheral blood, and their LTLs were 
compared between subject groups. Finally, the proportion of AD development was examined 
in the subject groups that are reclassified based on subjects' exposure to prenatal stress and 
there LTL.
Results: Cord-blood LTL was shorter in prenatally stressed infants than in unstressed ones 
(P = 0.026), which difference was still significant when subjects became 1 year old (P = 0.008).  
LTL of cord blood, as well as one of the 1-year peripheral blood, was not different according 
to later AD development at 1 year (P = 0.915 and 0.174, respectively). Shorter LTL made no 
increase in the proportion of later AD development in either prenatally high-stressed or low-
stressed groups (P = 1.000 and 0.473, respectively).
Conclusions: Cord-blood LTL may reflect subjects' exposure to maternal prenatal stress. 
However, the LTL shortening is not a risk factor of increasing AD development until the 
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age of 1, and a longer investigation may be necessary for validation. Currently, the results 
doubt the role of LTL shortening as a marker for risk assessment tool for the prenatal stress 
associated with AD development in the offspring.
Keywords: Atopic dermatitis; cohort studies; child; cord blood; telomere shortening; 
psychological stress
INTRODUCTION
Maternal prenatal stress affects the offspring's risk of noncommunicable diseases (NCDs),1 
including allergic diseases.2,3 Oxidative stress is thought to play a key mechanism by which 
the prenatal maternal stress affects childhood adverse health outcomes.1 Oxidative stress 
increases when subjects are under psychological stress, elevating the risk of contracting 
NCDs.4 The increased oxidative stress is also involved in the pathophysiology of childhood 
atopic dermatitis (AD).5
Subjects' exposure to oxidative stress cannot be easily quantified. Although the concentration 
of glutathione (GSH) or the ratio of GSH/oxidized GSH (GSSG) can represent the exposure 
to oxidative stress,6 the target specimens are hard to acquire. Recent studies proclaimed that 
telomeres shorten with progressive cell divisions,7 and the shortening of leukocyte telomere 
length (LTL) reflects the exposure to cumulative oxidative stress.8,9
The authors aimed to verify the LTL as a candidate biomarker for AD development as well 
as exposure to stress. In other words, we hypothesized that the LTL would be shortened in 
offspring following the exposure to prenatal maternal stress, and the LTL shortening could 
also be associated with AD development during early life. Therefore, we attemted to analyze 
blood samples archived in a birth cohort regarding their association with the exposure to 
prenatal maternal stress and with the AD development.
MATERIALS AND METHODS
Subjects
We selected a birth cohort (the COhort for Childhood Origin of Asthma and allergic diseases 
[COCOA]) that had displayed an epidemiologic association between prenatal maternal 
stress and the offspring's AD development.10,11 It archives the cord blood- and 1-year-old 
peripheral blood samples. In the COCOA study, prenatal maternal stress was evaluated using 
2 self-reported questionnaires at 36 weeks' gestation, namely the Center for Epidemiological 
Studies-Depression (CESD) 10 and the State-Trait Anxiety Inventory (STAI)-Trait subscale, 
which measures depression and anxiety, respectively.12,13
From the pre-defined 4 distinctive sampling pools, among subjects whose cord blood and 
1-year-old peripheral blood were both available, we selected 4 groups of 68 subject samples. 
Four groups are determined by their exposure to prenatal maternal stress (high or low stress) 
and their later development of AD up to their scheduled visit at the age of 1 (with later AD or 
without AD development). As a result, 4 groups are labeled as the high stress with later AD 
(HSWD), high stress without AD (HSOD), low stress with later AD (LSWD) and low stress 
without AD (LSOD) groups.
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To show the different characteristics between the groups, the low-stress group pools included 
subjects whose both CESD and STAI scores were in the lowest tertile. Whereas the high-stress 
group pools included subjects whose both CESD and STAI scores were in the highest tertile 
or those whose either CESD or STAI score was in the highest quartile. The other subjects 
were not considered the sampling candidate for this analysis. Subjects' AD development was 
ascertained by pediatric allergy specialists who made a clinical diagnosis after a detailed 
history and physical examination based on the criteria of Hanifin and Rajka up to their 1-year 
scheduled visit.14
Because of the insufficient number of subjects whose both cord-blood and 1-year peripheral-
blood samples were available, we measured LTLs from all available 23 subjects in the HSWD 
group, randomly-selected 20 subjects in the LSOD group, and randomly selected 15 subjects 
in both the HSOD and LSWD groups, respectively. After we exclude subjects whose cord-
blood LTL or 1-year peripheral-blood ones was not successfully measured, we finalized 68 
subjects (HSWD, 22 subjects; HSOD, 14 subjects; LSWD, 13 subjects; and LSOD, 19 subjects) 
as the population for analysis.
From the archived data in the COCOA cohort, 68 subjects' parameters regarding clinical 
characteristics were obtained. They include the child's sex, mode of delivery, gestational age 
and birth season. If subjects were born from March to May, they were regarded as being born 
in spring. From June to August, September to November and December to February were 
considered the summer, autumn and winter, respectively. Finally, maternal allergy history as 
well as the maternal and paternal age was also obtained.
The study protocol was approved by the Institutional Review Board of Seoul National 
University Hospital/Seoul National University College of Medicine (IRB No. 1701-006-819). 
Since subjects who provided research samples had agreed to secondary use in the original 
birth cohort, the requirement for written informed consent was waived.
LTL measurement
LTLs were determined from the average terminal restriction fragment (TRF) length, which 
was measured using a chemiluminescence technique according to the manufacturer's 
manual of a commercially available Telo TAGGG telomere length assay kit (Roche-Applied 
Science, Mannheim, Germany).15,16 DNA was extracted from the buffy coat of cord blood 
and 1-year-old peripheral blood using a DNA extraction kit (Qiagen, Crawley, UK). DNA 
samples (75 ng/mL) were digested with 10 U Rsa I and 10 U Hinf I for 2 hours at 37°C. DNA 
fragments were separated by electrophoresis at 150 V for 2 hours on 0.8% agarose gels. The 
DNA samples were then purified with 0.25 M HCl, denatured with NaOH-NaCl (0.5-1.5 M) and 
neutralized with Tris-NaCl (0.5-3 M, pH 7.5). According to the manufacturer's protocol, DNA 
samples were transferred onto a positively charged nylon membrane and fixed with Ultraviolet 
light for Southern blot analysis. Membranes were hybridized with a telomere repeat-specific 
digoxigenin (DIG)-labeled probe overnight at 42°C and washed thrice with 2× saline sodium 
citrate (SSC)/0.1% sodium dodecyl sulfate (SDS), followed by 0.2 × SSC/0.1% SDS.
Next, membranes were incubated with a DIG-specific antibody covalently coupled to 
alkaline phosphatase. Finally, the immobilized telomere probe was visualized using 
alkaline phosphatase-metabolizing CDP-Star® (Tropix Inc., Bedford, MA, USA). The 
telomere smear was obtained by printing the membrane on an autoradiograph film (Lumi-
Film chemiluminescent detection film; Roche-Applied Science) and scanning using a 
359https://e-aair.org https://doi.org/10.4168/aair.2019.11.3.357
LTL in the AD Development by the Prenatal Stress
densitometer. The mean TRF (an estimate of telomere length) of each sample was calculated 
using the following formula:
TRF = Σ (ODi)/Σ (ODi/Li)
where ODi is the optical density at a given position in the lane, and Li is the length in kilobase 
pairs at that position.
Statistical analysis
Data were analyzed using statistical software (SPSS ver 23.0; IBM Corp., Armonk, NY, USA) 
and R statistical software (version 3.3.2; R Foundation, Vienna, Austria). Changes in LTL 
during the first year of life were assessed by the paired t tests, and each group's yearly change 
was assessed using the Wilcoxon signed rank test. Differences in cord blood and 1-year-
old peripheral blood LTLs were assessed using the Mann-Whitney U test, and the absolute 
amount of attrition in LTLs across all 4 groups was evaluated using the Kruskal-Wallis test 
followed by post hoc Dunn's test with further P value adjustment by the Benjamini-Hochberg 
false discovery rate method.17 The proportion of later AD development according to the stress 
exposure and telomere length was assessed by the Fischer's exact test. The cutoff for shorter 
LTL was defined by the median of total subjects enrolled in this study. Differences were 
considered statistically significant when the P value was less than 0.05.
RESULTS
The distribution of subjects' clinical characteristics among the 4 sample groups is listed in 
Table 1. These all 4 groups were not different in their maternal and paternal age, gestational 
age, sex ratio, birth weight or delivery type. On the other hand, the ratio of subjects with a 
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Table 1. Distribution of the clinical characteristics among the 4 groups
Class HSWD HSOD LSWD LSOD P value
Number 22 14 13 19
Maternal CESD-10 11.5 (7.0–13.0) 18.0 (14.0–20.0) 2.0 (1.0–4.0) 3.0 (2.0–4.0) < 0.001
Maternal STAI-T 47.0 (45.0–51.0) 56.0 (55.0–59.0) 29.0 (28.0–33.0) 31.0 (28.0–33.5) < 0.001
Maternal age (yr) 34.0 (31.0–37.0) 36.5 (32.0–38.0) 33.0 (32.0–34.0) 31.0 (29.0–35.5) 0.097
Maternal allergy 6 (27.3) 7 (50.0) 5 (38.5) 1 (5.3) 0.030
Maternal asthma 1* 0 0 0
Maternal allergic rhinitis 5 7 3 1
Maternal AD 1 0 2 0
Paternal age (yr) 33.8 (31.6–36.8) 36.2 (31.8–38.1) 33.0 (32.0–34.1) 31.0 (29.1–34.9) 0.119
Child's sex (male/female) 15/7 10/4 8/5 10/9 0.666
Gestational age (wk) 38.8 (38.0–39.7) 39.1 (38.0–39.7) 39.3 (38.7–39.6) 39.9 (38.6–40.1) 0.435
Birth weight (kg) 2.96 (2.84–3.65) 3.21 (3.00–3.41) 3.16 (2.92–3.40) 3.19 (2.99–3.34) 0.948
Delivery type 0.664
Vaginal 13 (59.1) 8 (57.1) 10 (76.9) 11 (57.9)
Cesarean 9 (40.9) 6 (42.9) 3 (23.1) 8 (42.1)
Birth season 0.041
Spring 6 (27.3) 3 (21.4) 4 (30.8) 8 (42.1)
Summer 5 (22.7) 6 (42.9) 2 (15.4) 2 (10.5)
Fall 7 (31.8) 0 (0.0) 5 (38.5) 1 (5.3)
Winter 4 (18.2) 5 (35.7) 2 (15.4) 8 (42.1)
All variables are presented as the number (%) or the median (IQR).
HSWD, high stress with later atopic dermatitis; HSOD, high stress without atopic dermatitis development; LSWD, low stress with later atopic dermatitis; LSOD, 
low stress without atopic dermatitis development; AD, atopic dermatitis; CESD-10, Center for Epidemiological Studies-Depression 10; IQR, interquartile range; 
STAI-T, State-Trait Anxiety Inventory-Trait subscale.
*One subject had maternal history of both asthma and allergic rhinitis concomitantly.
maternal allergy history was different between the 4 groups with the lowest percentage in 
the LSOD group (P = 0.030). However, most of the maternal histories were about the allergic 
rhinitis (n = 16) and history of AD was only 3 cases (2 and 1 cases in the LSWD and HSWD 
group, respectively). The distribution of birth seasons was also different between groups 
without showing any specific pattern (P = 0.041).
The mean LTL from all cord blood samples was 14.4 ± 3.9 kbp. Fig. 1 showed the difference 
of cord-blood or 1 year-peripheral blood LTLs according to prenatal stress or later AD 
development. The cord-blood LTLs were shorter in high-stress groups than in low-stress ones 
(Mann-Whitney U test; median, 15.0 [interquartile range; IQR, 10.3, 15.0] vs. 15.0 [12.8, 18.0] 
kbp, P = 0.026; Fig. 1A), but they were not different between groups that later developed AD and 
those did not (median, 15.0 [IQR, 11.0, 16.0] vs. 15.0 [11.3, 18.0] kbp, P = 0.915; Fig. 1B). On 
the other hand, the median LTL from all 1-year-old peripheral blood samples was 11.5 ± 3.6 kbp, 
which was significantly shorter than that of cord blood samples (paired t test, P < 0.001). The 
1-year-old peripheral-blood LTLs were still shorter in high-stress groups than in the low-stress 
ones (Mann-Whitney U test; median, 10.0 [IQR, 8.6, 12.0] vs. 13.0 [9.0, 17.0] kbp, P = 0.008; 
Fig. 1C), but they were not different between groups that later developed AD and those did not 
(median, 10.0 [IQR, 8.6, 13.0] vs. 12.0 [8.6, 16.5] kbp, P = 0.174; Fig. 1D).
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Fig. 1. Comparison of the telomere length of cord blood leukocytes according to (A) exposure to prenatal stress and (B) AD development. The telomere lengths 
from 1-year-old peripheral blood were also compared according to (C) exposure to prenatal stress and (D) AD at the age of 1 year. 
AD, atopic dermatitis; HSWD, high stress with later atopic dermatitis; HSOD, high stress without atopic dermatitis development; LSWD, low stress with later 
atopic dermatitis; LSOD, low stress without atopic dermatitis development.
The changes in each subject' LTL during their first year of life between the stress/AD groups 
are depicted in Fig. 2. Either prenatally stressed or later AD-developed groups presented a 
significant decrease in LTL during the year (Wilcoxon signed rank test; cord-blood vs. 1-year-
old peripheral blood; HSWD group: median, 13.5 [IQR, 10.0, 15.25] vs. 10.0 [8.6, 12.25] kbp, 
P = 0.005, Fig. 2A; HSOD group: median, 15.0 [IQR, 12.75, 15.75] vs. 10.0 [7.3, 12.0] kbp,  
P = 0.004, Fig. 2B; and LSWD group: median, 16.0 [IQR, 15.0, 18.0] vs. 10.0 [8.8, 13.0] kbp, 
P = 0.003, Fig. 2C). On the other hand, those in neither prenatally stressed nor later AD-
developed group did not show any significant change (median, 15.0 [IQR, 10.0, 19.0] vs. 15.0 
[10.0, 17.0] kbp, P = 0.434; Fig. 2D).
LTLs of 1-year-peripheral blood and their changes during their first year of life according to 
subject groups were displayed in Fig. 3. The 1-year median LTL in the LSOD group was 15.0 
[IQR, 10.0, 17.0] kbp, which is the longest among the 4 subject groups (Kruskal-Wallis test,  
P = 0.016; Fig. 3A). In post hoc analysis, 1-year-peripheral blood LTL were significantly longer 
in the LSOD groups than in the HSWD group (median, 10.0 [IQR, 8.6, 12.25] kbp) and HSOD 
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Fig. 2. Changes in telomere length between cord blood and 1-year-old peripheral blood leukocytes from subjects 
in the (A) HSWD, (B) HSOD, (C) LSWD and (D) LSOD groups. HSWD, high stress with later atopic dermatitis; 
HSOD, high stress without atopic dermatitis development; LSWD, low stress with later atopic dermatitis; LSOD, 
low stress without atopic dermatitis development.
group (median, 10.0 [IQR, 7.3, 12.0] kbp) (P = 0.032 and 0.021, respectively). The amount of 
LTL changes during the year were not equal (Kruskal-Wallis test, P = 0.013; Fig. 3B): it was the 
most prominent in LSWD group. In post hoc analysis, the change during the first year of life 
was more prominent in LSWD than LSOD group (Dunn's test; median, −6.0 [IQR, −3.0, −7.0] 
vs. −1.0 [−3.7, 2.0] kbp, P = 0.017), but the change was not different between in HSWD and in 
HSOD group (Dunn's test; median, −1.7 [IQR, −5.25, 0.0] vs. −3.2 [−7.7, −0.75] kbp, P = 0.265).
Table 2 presented the proportion of subjects who developed AD at 1 year according to 
subjects' cord-blood LTL. Shorter telomere length did not increase the proportion of AD in 
either group (odds ratio [OR], 0.833; 95% confidence interval [CI], 0.301-2.309; P = 0.799). 
Moreover, further analyses showed that shorter telomere length did not influence the odds 
of the AD in either high-stress or low-stress group (high-stress group: OR, 0.927; 95% CI, 
0.184-4.687; P = 1.000; low-stress group: OR, 0.500; 95% CI, 0.119-2.100; P = 0.473).
DISCUSSION
Prenatally-stressed groups had already presented shorter LTL at birth than less-stressed ones. 
This difference remained significant until subjects became 1 year old. On the other hand, 
cord blood LTLs were not different between subjects who were doomed to develop the AD 
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Fig. 3. Box- and-Whisker plots showing (A) the telomere lengths from 1-year-old peripheral blood leukocytes and (B) the decrease in the telomere length during 
the first year of life between groups according to stress exposure and later AD development. Horizontal small bars represent the 10th–90th percentile range, and 
the boxes indicate the median and IQR. 
AD, atopic dermatitis; HSWD, high stress with later atopic dermatitis; HSOD, high stress without atopic dermatitis development; LSWD, low stress with later 
atopic dermatitis; LSOD, low stress without atopic dermatitis development; IQR, interquartile range.
Table 2. Proportion of atopic dermatitis development according to the level of cord blood telomere length in each stress group
Group Shorter telomere length Longer telomere length Odds ratio (95% CI) P value
Overall 23/46 12/22 0.833 (0.301–2.309) 0.799
High stress 17/28 5/8 0.927 (0.184–4.687) 1.000
Low stress 6/18 7/14 0.500 (0.119–2.100) 0.473
CI, confidence interval.
and who were not, neither were the ones of the 1-year peripheral blood. When we reclassify 
subjects according to subjects' prenatal stress and the cord-blood LTL, shorter cord-blood 
LTLs displayed no significant increase in the proportion of AD development in either high-
stressed or low-stressed groups, which implicates the LTL shortening is not a risk factor for 
AD development up to the age of 1. This study is the first attempt to validate the oxidative 
stress markers for the increased risk for AD development.
The mean LTL measured in this study from all cord blood samples was longer than that of 
previous reports.16,18 One study on the infant from mainly hypertensive mothers reported a 
mean cord blood LTL of 10.95 ± 0.09 kbp in males and 11.07 ± 0.08 kbp in females.16 Another 
study in the United States reported a mean cord blood LTL of 6.98 ± 0.41 kbp from the high-
stressed groups and of 8.74 ± 0.24 kbp from the low-stressed ones, but their mothers consisted 
mainly of a specific ethnicity, African Americans.18 We believe this discrepancy would not doubt 
the accuracy of our LTL measurement because ethnicity can affect the LTL and no reference 
value is known for Korean babies.19 Moreover, we assessed the LTL by measuring the mean 
TRF length via Southern blots, which is more accurate than the quantitative polymerase chain 
reaction analysis.20 We assigned 1 dedicated person and 2 assistants in measuring the mean TRF 
length, which would minimize the interpersonal variation.
The 1-year peripheral blood LTLs as well as the cord blood ones were short in subjects who 
were exposed to high prenatal maternal stress. Although it has recently been replicated that 
prenatal maternal stress shortens the offspring's LTL at birth,21,22 no information is available 
until when the prenatal stress may affect the LTL shortening significantly. This study shows 
the impact of prenatal stress exposure may persist for at least the first year of one's life 
significantly. Moreover, the impacts are comparable to that of AD development because 1-year 
LTL in the HSOD group presented the comparable shortening with those in the HSWD as 
well as the LSWD group and a significant shortening than those in the LSOD group.
The shorter cord blood LTL in the prenatal stress-exposure group was consistent with our 
previous report that the ratio of placental reduced GSH and GSSG was decreased following 
maternal prenatal stress exposure.11 Considering that both telomere shortening and the 
reduced ratio of GSH/GSSG are associated with oxidative stress exposure,6,8 prenatal stress may 
have exposed the fetus to more oxidative stress. Moreover, since oxidative stress is thought to be 
related to AD,5 these findings justify our hypothesis that LTL could play a role of the biomarker 
that reflects the exposure to prenatal stress and that predict the risk of AD development at the 
same time. Contrary to our assumption, even though the oxidative stress may be associated 
with AD, it seems not directly or specifically induce AD development because LTL shortening 
was not different between HSWD and HSOD groups, and the shortening was most prominent 
in the LSWD group during the first year of life. In other words, shortened LTL may not be 
interpreted to induce AD development for itself; instead, some AD-inducing factors other than 
prenatal maternal stress may also have affected LTL shortening during the first year of life.
In this study, we further evaluated the proportion of AD development in 4 groups of subjects 
that were reclassified according to the exposure to prenatal maternal stress and the LTL 
shortening, by which we aimed to assess the additive role of LTL shortening when it was 
combined with the exposure to prenatal maternal stress. As a result, the proportion of 
AD development was not increased by the shorter LTL compared with the others in either 
prenatally high-stressed or low-stressed groups. This result also discards the efficacy of LTL 
as a marker for later AD development.
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We should mention some limitations of our study. First, we have confined AD to subjects 
that had AD before the age of 1 year, which may be complicated by subjects not-yet, but 
later showing AD. Nonetheless, we had to choose the age of 1 year because 60% of subjects 
with AD presents symptoms during the first year of life and, even in an Asian cohort, 78.5% 
of AD subjects were diagnosed before 12 months of age.23,24 Moreover, before the age of 
2 subjects begin to present their respiratory allergies or to outgrow their AD, which may 
complicate assessing the relationship between the LTL and AD development. Secondly, we 
have not assessed LTL from the whole population: the shortage of financial support led us to 
analyze samples of 4 typical groups of subjects instead, which eventually limits the findings 
to be generalized in the whole population. Thirdly, we could not present specific pathways 
that can replace the oxidative stress, by which the prenatal maternal stress would make 
subjects prone to AD development. Despite all these limitations, our study is still valuable 
to have investigated the relationship between the prenatal stress-exposure, LTL, and the AD 
development from the birth cohort samples.
In conclusion, cord blood LTL was shorter in prenatally stressed infants than in unstressed 
ones, which difference was still significant when subjects became 1 year old. Considering 
that cord blood LTL was not different according to later AD development at 1 year, shorter 
LTL made no increase in the proportion of later AD development in either prenatally high-
stressed or low-stressed groups. These results implicate that the LTL shortening is not a risk 
factor for increasing AD development until the age of 1, and a longer investigation may be 
necessary for validation. Currently, the results doubt the role of LTL shortening as a marker 
for risk assessment tool for the maternal stress-associated AD development in the offspring.
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